Discovery of novel and potent harringtonine derivative P2 via systematic structure-activity Optimization: Semi-Synthesis, anti-leukemia activity, and mechanism study.

Synribo (omacetaxine mepesuccinate) - Teva

http://www.ncbi.nlm.nih.gov/pubmed/41506044

Biao Jiang; Dejin Zhang; Fang Bai; Hongli Chen; Ping Xing; Qianqian Yin; Shuting Shen; Xiaoyu Wang; Xinyu Ding; Yuanchao Li; Zhongli Xu

Jan 9, 2026